BIOMERICA INC 10-Q

ITEM 5. OTHER INFORMATION Dr. Jane Emerson, notified the Board that she is stepping down as a member of the Board, effective November 1, 2025. Dr, Emerson’s resignation did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. ITEM 6. EXHIBITS The following exhibits are filed or furnished as part of this quarterly report on Form 10-Q: Exhibit No. Description 31.1** Certificate of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act 31.2** Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act 32.1** Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act 32.2** Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act 101 Interactive data files pursuant to Rule 405 Regulation S-T, as follows: 101.INS-XBRL Instance Document 101.SCH-XBRL Taxonomy Extension Schema Document 101.CAL-XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF–XBRL Taxonomy Extension Definition Linkbase Document 101.LAB-XBRL Taxonomy Extension Label Linkbase Document 101.PRE-XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibits 101) * Filed herein. ** Filed herewith. 20 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has fully caused this report to be signed on its behalf by the undersigned thereunto duly authorized. BIOMERICA, INC. Date: October 14, 2025 By: /S/ Zackary S. Irani Zackary S. Irani Chief Executive Officer (Principal Executive Officer) Date: October 14, 2025 By: /S/ Gary Lu Gary Lu Chief Financial Officer (Principal Financial Officer) 21